Clinical Trial Update: Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus. [Phase 1]

View source ↗

Summary

A Phase 1 study comparing single doses of three modified-release formulations of PF-04937319 with an immediate-release sparing-tablet in adults with Type 2 Diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-04937319

Snippet

Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2016-03-04